Demystifying the process of complying with 21 CFR Part 11

There’s been a lack of clarity around what’s needed to comply with 21 CFR Part 11, the US Food and Drug Administration’s regulations for inspecting electronic training records held by organizations.

Implementing electronic signatures and being able to clearly audit their use has often been a considerable challenge for businesses in the life sciences and pharma sectors.

This is an essential requirement for companies in these sectors looking to comply with the FDA’S CFR regulations. In-depth and rigorous auditing is increasingly sought-after by organizations in other sectors too, such as healthcare.

How a more detailed level of reporting leads to 21 CFR Part 11 compliance

Read the full story by

Tags:

RELATED READS
How a pharmaceutical market leader used NetDimensions to eliminate compliance risk Future-proof your organization with the right talent development strategy
We are updating our Privacy Policy, so please make sure you take a minute to review it. As of May 25, 2018 your continued use of our services will be subject to this new Privacy Policy.
Review Privacy Policy OK